On Tuesday, March 19, the FDA announced approval of (brand name) Zulresso, a first of it’s kind medication for Postpartum Depression. Zulresso (generic name is brexanolone) was developed through clinical trials by pharmaceutical company, Sage Therapeutics. You can find more about the development and history of Zulresso HERE. The medication is potentially a game-changer for...Read More

Better Beginnings is a first of its’ kind stand-alone health facility in Florida offering a range of care for pregnant and postpartum women including the Southeasts’ first Mother/Baby partial hospitalization day program for women experiencing more severe levels of anxiety, depression and other emotional distress symptoms.  The program offers rapid access to specialized care in...Read More